211 related articles for article (PubMed ID: 10704616)
1. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
Jain SK; McVie R; Meachum ZD; Smith T
Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
[TBL] [Abstract][Full Text] [Related]
2. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
Jain SK; McVie R; Jaramillo JJ; Chen Y
Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
Julier K; Mackness MI; Dean JD; Durrington PN
Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein abnormalities in well-treated type II diabetic patients.
Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.
Sánchez-Quesada JL; Pérez A; Caixàs A; Rigla M; Payés A; Benítez S; Ordóñez-Llanos J
J Clin Endocrinol Metab; 2001 Jul; 86(7):3243-9. PubMed ID: 11443196
[TBL] [Abstract][Full Text] [Related]
6. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
[TBL] [Abstract][Full Text] [Related]
8. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
[TBL] [Abstract][Full Text] [Related]
10. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.
Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Arrol S; Mackness M
Arterioscler Thromb; 1992 Aug; 12(8):920-8. PubMed ID: 1637789
[TBL] [Abstract][Full Text] [Related]
12. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
[TBL] [Abstract][Full Text] [Related]
13. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
[TBL] [Abstract][Full Text] [Related]
16. LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation.
Jenkins AJ; Klein RL; Chassereau CN; Hermayer KL; Lopes-Virella MF
Diabetes; 1996 Jun; 45(6):762-7. PubMed ID: 8635650
[TBL] [Abstract][Full Text] [Related]
17. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
Sørensen LP; Andersen IR; Søndergaard E; Gormsen LC; Schmitz O; Christiansen JS; Nielsen S
Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686
[TBL] [Abstract][Full Text] [Related]
18. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
[TBL] [Abstract][Full Text] [Related]
20. Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1.
Strobl W; Widhalm K; Schober E; Frisch H; Pollak A; Westphal G
Acta Paediatr Scand; 1985 Nov; 74(6):966-71. PubMed ID: 4090971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
